TAG-1 is an inhibitor of TGFbeta2-induced neuronal death via amyloid beta precursor protein

Nobuyuki Tachi1, Yuichi Hashimoto, Mikiro Nawa

  • 1Department of Pharmacology, Tokyo Medical University, 6-1-1 Shinjuku, Tokyo 160-8402, Japan.

Insights

Transient axonal glycoprotein-1 (TAG-1) protects neurons from TGFbeta2-induced cell death by preventing TGFbeta2 binding to amyloid precursor protein (APP). Age-related decreases in TAG-1 may increase Alzheimer

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Transforming growth factor beta 2 (TGFbeta2) induces neuronal cell death by binding to amyloid precursor protein (APP) and activating an intracellular signaling cascade.
  • Transient axonal glycoprotein-1 (TAG-1), a novel APP ligand, influences APP intracellular domain release and transcriptional activity.

Purpose of the Study:

  • To investigate the role of TAG-1 in modulating TGFbeta2-mediated neuronal cell death via APP.
  • To explore the potential link between age-related changes in TAG-1 expression and neuronal vulnerability in Alzheimer's disease.

Main Methods:

  • Investigated the interaction between TAG-1, TGFbeta2, and APP in neuronal cells.
  • Assessed the effect of TAG-1 on TGFbeta2 binding to APP using biochemical assays.
  • Examined TAG-1 expression levels in murine hippocampal neurons at different ages.

Main Results:

  • TAG-1 inhibits TGFbeta2-induced neuronal cell death by attenuating TGFbeta2 binding to APP in a gamma-secretase-independent manner.
  • TAG-1 expression is present in young adult murine hippocampal neurons but decreases with age.

Conclusions:

  • Age-related reduction in TAG-1 expression may render neurons more susceptible to TGFbeta2-induced cell death.
  • This mechanism involving TAG-1, APP, and TGFbeta2 may contribute to Alzheimer's disease pathogenesis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...